NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Purple Biotech Ltd (TA: KTOV)

 
KTOV Technical Analysis
5
As on 2nd Feb 2026 KTOV STOCK Price closed @ 1.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.53 & Strong Sell for SHORT-TERM with Stoploss of 7.11 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

KTOVSTOCK Price

Open 1.10 Change Price %
High 1.10 1 Day -0.10 -9.09
Low 1.00 1 Week -0.10 -9.09
Close 1.00 1 Month -0.20 -16.67
Volume 3950575 1 Year -5.80 -85.29
52 Week High 12.90 | 52 Week Low 1.00
 
TA Israel Most Active Stocks
TA125 2008.05 1.06%
BEZQ 789.10 -1.15%
BONS 41.30 9.55%
ORL 101.10 -0.88%
APLY 73.90 15.47%
ARDM 73.90 15.47%
KTOV 1.00 -9.09%
NERZ 1055.00 17.22%
POLI 7794.00 1.39%
LUMI 7521.00 0.64%
 
TA Israel Top Gainers Stocks
INSL 198.00 30.01%
EFNC 198.00 30.01%
TDGN-L 171.50 17.55%
NERZ 1055.00 17.22%
MCRNT 372.50 16.84%
APLY 73.90 15.47%
ARDM 73.90 15.47%
AUGN 706.20 12.90%
CHR 75.00 11.77%
CHR 75.00 11.77%
 
TA Israel Top Losers Stocks
MDVI 90.80 -34.20%
KMNK 51.00 -23.19%
SVRT 174.00 -20.18%
ICB 2000.00 -20.00%
BSP 2000.00 -20.00%
BSP 2000.00 -20.00%
BSP 2000.00 -20.00%
BSP 2000.00 -20.00%
BSP 2000.00 -20.00%
BSP 2000.00 -20.00%
 
 
KTOV
Daily Charts
KTOV
Intraday Charts
Whats New @
Bazaartrend
KTOV
Free Analysis
 
KTOV Important Levels Intraday
RESISTANCE1.19
RESISTANCE1.13
RESISTANCE1.09
RESISTANCE1.05
SUPPORT0.95
SUPPORT0.91
SUPPORT0.87
SUPPORT0.81
 
KTOV Forecast February 2026
4th UP Forecast30.68
3rd UP Forecast21.16
2nd UP Forecast15.28
1st UP Forecast9.39
1st DOWN Forecast-7.39
2nd DOWN Forecast-13.28
3rd DOWN Forecast-19.16
4th DOWN Forecast-28.68
 
KTOV Weekly Forecast
4th UP Forecast30.68
3rd UP Forecast21.16
2nd UP Forecast15.28
1st UP Forecast9.39
1st DOWN Forecast-7.39
2nd DOWN Forecast-13.28
3rd DOWN Forecast-19.16
4th DOWN Forecast-28.68
 
KTOV Forecast2026
4th UP Forecast39.54
3rd UP Forecast27.18
2nd UP Forecast19.54
1st UP Forecast11.9
1st DOWN Forecast-9.9
2nd DOWN Forecast-17.54
3rd DOWN Forecast-25.18
4th DOWN Forecast-37.54
 
 
KTOV Other Details
Segment EQ
Market Capital 227007808.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
KTOV Address
KTOV
 
KTOV Latest News
 
Your Comments and Response on Purple Biotech Ltd
 
KTOV Business Profile
Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs. It operates through two segments, Oncology, and Pain and Hypertension. The company's marketed products include Consensi, a fixed-dose combination of celecoxib and amlodipine besylate for the simultaneous treatment of osteoarthritis pain and hypertension in the United States, as well as in China and South Korea. Its oncology pipeline includes NT-219, a small molecule that is advancing as a monotherapy treatment of advanced solid tumors and in combination with cetuximab for the treatment of recurrent or metastatic squamous cell carcinoma of head and neck cancer in a planned phase 1/2 study; and CM-24, a monoclonal antibody blocking CEACAM1 that is being developed as a combination therapy with anti-PD1 checkpoint inhibitors for the treatment of non-small cell lung cancer and pancreatic cancer. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. Purple Biotech Ltd. is headquartered in Tel Aviv, Israel. Address: One Azrieli Center, Tel Aviv, Israel, 6701101
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service